← Back to Search

Cognitive Behavioral Therapy + Valuation for Depression and Anxiety

N/A

Recruiting

Research Sponsored by Virginia Polytechnic Institute and State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Mood, anxiety, or anhedonia symptoms that affect functioning

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study entrance to exit, an average of 12 weeks

Awards & highlights

Study Summary

This trial looks at how different people react to winning or losing, and if these responses are different for people who have depression, anhedonia, or anxiety.

Who is the study for?

This trial is for individuals who can see a computer display, are experiencing mood issues, anxiety, or anhedonia (lack of pleasure) that affect their daily life, speak English fluently, and can play simple computer games. It's not for those with MRI contraindications, seizure disorders, significant head injuries, hormone disorders, recent electroconvulsive therapy or chemotherapy treatments for cancer.Check my eligibility

What is being tested?

The study is testing how cognitive behavioral therapy and two types of valuation tasks (with and without instruction) influence the way people perceive rewards and losses. The goal is to understand these processes in those suffering from depressed moods or anxiety.See study design

What are the potential side effects?

Since this trial involves psychological assessments and non-invasive therapies like cognitive behavioral therapy rather than medication or surgical interventions, side effects are minimal but may include temporary emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I experience mood swings, anxiety, or lack of pleasure that impacts my daily life.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ study entrance to exit, an average of 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~study entrance to exit, an average of 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and study entrance to exit, an average of 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change in proportion correct on the 'N-arm bandit learning task'

Secondary outcome measures

change in anhedonia symptoms (anhedonia subscale; Mood and Anxiety Symptom Questionnaire)

change in anxiety symptoms (anxiety subscale; Mood and Anxiety Symptom Questionnaire)

change in depression symptoms (Beck Depression Inventory)

Trial Design

3Treatment groups

Active Control

Group I: Cognitive behavioral therapyActive Control1 Intervention

cognitive behavioral therapy for depression, anxiety, and/or anhedonia

Group II: Valuation with instructionActive Control1 Intervention

repeat laboratory sessions of a reward/loss learning computer game with specific instructions

Group III: Valuation without instructionActive Control1 Intervention

repeat laboratory sessions of a reward/loss learning computer game without specific instructions

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor

142 Previous Clinical Trials

27,554 Total Patients Enrolled

Media Library

Cognitive Behavioral Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05384158 — N/A

Neurobehavioral Components of Reward and Loss Valuation Research Study Groups: Cognitive behavioral therapy, Valuation with instruction, Valuation without instruction

Neurobehavioral Components of Reward and Loss Valuation Clinical Trial 2023: Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT05384158 — N/A

Cognitive Behavioral Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05384158 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being admitted to this research endeavor?

"Affirmative. The information from clinicaltrials.gov confirms that the trial, which was made public on August 1st 2021, is presently enrolling participants. A total of 252 individuals are required for this study at a single location."

Answered by AI

How many participants have been enrolled in this research project?

"Affirmative, the information posted on clinicaltrials.gov suggests that recruitment for this medical trial is still underway. It was initially published on August 1st 2021 and had its most recent edit performed on May 17th 2022. A total of 252 patients will be admitted at a single site."

Answered by AI